# Tulex Pharmaceuticals Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/tulex-pharmaceuticals-inc/e9839d9b-b973-49c3-916a-4ca187d606dd

> Inspection records and compliance data for Tulex Pharmaceuticals Inc. in Cranbury, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Tulex Pharmaceuticals Inc.
- FEI Number: 3011875665
- City: Cranbury
- State: New Jersey
- Country Name: United States
- Address Line 1: 5 Cedarbrook Dr
- Zip Code: 08512
- Business Operations: FDF MANUFACTURE

## Related Documents

- [483 - Tulex Pharmaceuticals Inc. - 2025-03-24](https://www.globalkeysolutions.net/records/483/tulex-pharmaceuticals-inc/a13a486c-928d-431f-847a-5d4f12d53869) — source: FDA, date: March 24, 2025
- [FDA Inspection 1264812 - Tulex Pharmaceuticals Inc. - 2025-03-24](https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/3085aa66-b7a0-4815-9e58-5d1875897b55) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 24, 2025
- [FDA Inspection 1256966 - Tulex Pharmaceuticals Inc. - 2024-12-05](https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/2d3edd0e-d697-42dc-b14f-1cf6ba79a099) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 5, 2024
- [FDA Inspection 1232755 - Tulex Pharmaceuticals Inc. - 2024-02-29](https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/f617ec30-1c21-434a-bc70-2cb48d9caabe) — classification: No Action Indicated (NAI), source: FDA, date: February 29, 2024
- [FDA Inspection 1129002 - Tulex Pharmaceuticals Inc. - 2020-08-14](https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/8686b7e1-fa12-491d-8f1f-3a1c0dacac55) — classification: No Action Indicated (NAI), source: FDA, date: August 14, 2020
- [483 - Tulex Pharmaceuticals Inc. - 2019-12-12](https://www.globalkeysolutions.net/records/483/tulex-pharmaceuticals-inc/172155ac-360f-439f-b295-e3c9ea28aa8e) — source: FDA, date: December 12, 2019
- [FDA Inspection 1031819 - Tulex Pharmaceuticals Inc. - 2017-11-21](https://www.globalkeysolutions.net/records/fda_inspections/tulex-pharmaceuticals-inc/a0867f8e-3b5f-4fc5-ad03-788d5b196185) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2017

## Related Companies

- [Cetylite Industries, Inc.](https://www.globalkeysolutions.net/companies/cetylite-industries-inc/750fff5e-267e-48ab-9e37-75b98e70cea3)
- [Dendreon Pharmaceuticals LLC](https://www.globalkeysolutions.net/companies/dendreon-pharmaceuticals-llc/68ccd67e-0a3a-41cb-ae30-e9e10a6eaef5)
- [Ferring Production Inc.](https://www.globalkeysolutions.net/companies/ferring-production-inc/630420f9-f163-4b8d-91f5-d4922708508e)
- [Davion Inc](https://www.globalkeysolutions.net/companies/davion-inc/2876e97d-f0e3-437f-b69f-db6c68c2e3ea)
- [Encube Ethicals Pvt. Ltd.](https://www.globalkeysolutions.net/companies/encube-ethicals-pvt-ltd/2bba05cc-6e4f-4020-8f97-3e56020b33a2)
- [Osmotica Pharmaceutical US LLC](https://www.globalkeysolutions.net/companies/osmotica-pharmaceutical-us-llc/5dae0d09-f070-4928-97f6-cfe7043ff133)
- [Noble Pharma, LLC](https://www.globalkeysolutions.net/companies/noble-pharma-llc/7fd1f37f-ba04-49a3-a115-ad7110e9f8a5)
- [DPT Laboratories Ltd](https://www.globalkeysolutions.net/companies/dpt-laboratories-ltd/b2d45aa5-6cf4-4401-87a2-35470321dc30)
- [Unither Manufacturing LLC.](https://www.globalkeysolutions.net/companies/unither-manufacturing-llc/1af71ec2-4e77-473b-b1ba-28318c362e05)
- [SOCIETAL CDMO SAN DIEGO, LLC](https://www.globalkeysolutions.net/companies/societal-cdmo-san-diego-llc/62dca7b3-eae0-4594-9138-e540f9e03d62)

## Related Officers

- [Adetutu M. Gidado](https://www.globalkeysolutions.net/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)
- [Suchan Kim](https://www.globalkeysolutions.net/people/suchan-kim/1acf9a36-036f-48a8-a8a4-caa290830e37)
- [James R. Birkenstamm](https://www.globalkeysolutions.net/people/james-r-birkenstamm/eb1192a4-3c76-4243-886c-9b5805871ad1)